Monitor this situation.

Unsubscribe anytime.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 7 sources · 3 days · First seen 17 days ago · Last updated 15 days ago

McKesson acquisition of Precision Medicine Group

Overview

McKesson Corporation has agreed to acquire Precision Medicine Group, LLC, for approximately $2.25 billion. The acquisition is intended to bolster McKesson’s clinical research and biopharmaceutical commercialization capabilities, specifically within its oncology and multi-specialty segment.

Precision Medicine Group provides various services to biotechnology and pharmaceutical companies, including biomarker intelligence, laboratory services, market access consulting, and global clinical research organization capabilities. The transaction remains subject to regulatory approvals.

Entities

Precision Medicine Group · McKesson · U.S. Securities and Exchange Commission · Lundbeck · EVERSANA

Timeline

15 days ago

[BUSINESS] 4 sources
McKesson to acquire Precision Medicine Group for US$2.25 billion
McKesson has agreed to acquire Precision Medicine Group for US$2.25 billion to expand its clinical research and biopharmaceutical commercialization services.
17 days ago

[BUSINESS] 3 sources
Lundbeck and McKesson announce major pharma industry developments
Lundbeck and EVERSANA are partnering to scale AI-driven commercialization, while McKesson has agreed to acquire Precision Medicine Group for $2.25 billion.

Sources

aijourn.com · alobbs.com · cybernoz.com · financial-news.co.uk · healthcaremea.com · marketwire.com · pharmexec.com